MEI Pharma Inc expected to post a loss of 19  cents a share - Earnings Preview

Lite Strategy

06/09/2022 21:16

* MEI Pharma Inc  MEIP.OQ   MEIP.O  is expected to show a
fall in
quarterly revenue when it reports  results on September 8. 
    * The San Diego California-based  company is expected to
report  a
52.9% decrease in revenue to $4.77 million from $10.12 million a
year ago, according to the mean estimate from 7 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for MEI Pharma Inc is
for a
loss of 19 cents per share. For the same quarter last year, the
company reported a loss of 5 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for MEI Pharma
Inc is
$3​, above​ its last closing price of $0.50. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.18       -0.18      -0.07     Beat    61.6
 Dec. 31 2022  -0.20       -0.20      -0.05     Beat    75.3
 Sep. 30 2021  -0.12       -0.13      -0.11     Beat    12.7​
 Jun. 30 2021  -0.18       -0.17      -0.05     Beat    71.4
 ​​Mar.        -0.17       -0.16      -0.28     Missed  -72.3
 31 2021                                                
 Dec. 31 2020  -0.14       -0.13      -0.10     Beat    24.7​
 Sep. 30 2020  -0.07       -0.08      -0.02     Beat    75.6
 Jun. 30 2020  -0.14       0.22       -0.19     Missed  -188.4
 This summary was machine generated September 6 at 20:16 GMT. 
All figures in US dollars  unless otherwise stated